Written Question·Department of Health and Social Care·UIN 28089
Givinostat
Tabled: 3 February 2025
Answered: 10 February 2025
Question
Jo Platt
Labour (Co-op) — Leigh and Atherton
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with (a) NHS England and (b) ITF Pharma UK on the provision of (i) resources and (ii) guidance to NHS trusts to enable them to take part in the Early Access Progr
Answer
Karin SmythITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 28089) →